Advertisement

Drug Safety

, Volume 31, Issue 10, pp 885–885 | Cite as

Early Post-Marketing Pharmacovigilance of BLASTOFERON®: An Interferon Beta 1a Biosimilar

  • M. Kauffman
  • M. Papouchado
  • E. Gonzalez
  • A. Sterin-Prync
  • A. Vidal
  • R. Diez
  • H. Ferro
Abstract
  • 29 Downloads

Keywords

Sentinel Site Relapse Remit Pharmacovigilance Action Biosimilar Product Pharmacovigilance Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • M. Kauffman
    • 1
  • M. Papouchado
    • 2
  • E. Gonzalez
    • 3
  • A. Sterin-Prync
    • 2
  • A. Vidal
    • 2
  • R. Diez
    • 1
  • H. Ferro
    • 1
  1. 1.Drug Safety Unit. Bio Sidus S.A.Argentina
  2. 2.Bio Sidus S.AArgentina
  3. 3.Centro de Diagnostico Molecular S.A.Argentina

Personalised recommendations